 Product Search |
|
| Input Product Name Or Cas No. |
| Category |
| Products |
 1-(4-(tert-butyl)phenyl)hexahydrothiopyr |
| 1-(4-(tert-butyl)phenyl)hexahydrothiopyr |
| 2H-Thiopyranium, tetrahydro-1-phenyl-, b |
| 1-(2-oxo-2-phenylethyl)tetrahydro-1H-thi |
| 2,8-Dibenzothiophenedicarboxylic acid |
| bis(1-phenylcyclopentyl) 2-((3-(trimetho |
| Benzo[b]thiophene, 5-fluoro-, 1-oxide |
| bis(1-(tert-butyl)cyclopentyl) 2-((3-(tr |
| Sulfonium, (4-carboxyphenyl)diphenyl-, c |
| Sulfonium, [4-[2-[(1-methylcyclopentyl)o |
| Sulfonium, bis(4-iodophenyl)phenyl-, bro |
| 1-(tert-butyl)cyclopentyl 3-((3-(trimeth |
| di(cyclopent-2-en-1-yl) 2-((3-(trimethox |
| Sulfonium, [4-[[(1-ethylcyclopentyl)oxy] |
| 1-isopropylcyclopentyl 3-((3-(trimethoxy |
| 1-isopropylcyclopentyl 2-bromoacetate |
| 1-phenylcyclopentyl 2-bromoacetate |
| 1-methylcyclopentyl 4-bromo-2-fluorobenz |
| 1-ethylcyclopentyl 4-bromo-2-fluorobenzo |
| 9-[4-(1,1-Dimethylethyl)-2-pyridinyl]-9H |
| 9-(6-Bromo-2-pyridinyl)-9H-carbazole |
| 1,5-Dichloro-2,4-dimethylbenzene |
| 1-(3-Bromophenyl)-3,5-dimethyl-1H-pyrazo |
| 5-Methoxy-2-(2-phenylethynyl)benzenamine |
| 1-[3-Bromo-5-(1,1-dimethylethyl)phenyl]- |
| 3,5-Dimethyl-4-(4,4,5,5-tetramethyl-1,3, |
| 1-(3-Methoxyphenyl)-1H-benzimidazole |
| 2-[3-(1H-Benzimidazol-1-yl)phenoxy]-9-[4 |
| 3-(1H-Benzimidazol-1-yl)phenol |
| 1-[3-Bromo-5-(1,1-dimethylethyl)phenyl]- |
| 4-[2,6-Bis(1-methylethyl)phenyl]-3-pheny |
| Dibenzofuran, 1-bromo-8-(1,1-dimethyleth |
| 1-(3-Bromophenyl)-5-(1,1-dimethylethyl)- |
| B-[3-(1H-Benzimidazol-1-yl)phenyl]boroni |
| (3,5-bis(2-phenylpropan-2-yl)phenyl)(mes |
| 1H-Imidazole, 2-(3-bromophenyl)-1-phenyl |
| 1-(2-Fluoro-4-pyridinyl)-1H-benzimidazol |
| Boronic acid, B-[3-[4-(1,1-dimethylethyl |
| 1-(3-Bromophenyl)-3,5-bis(1,1-dimethylet |
| 2-Fluoro-4-methyl-5-phenylpyridine |
| 2-Bromo-7-methyl-9H-carbazole |
| Pyridine, 2-fluoro-5-methyl-4-phenyl- |
| 4-[4-(Dimethoxymethyl)-1-piperidinyl]-2- |
| Methyl 2-(bromomethyl)-4-[4-(dimethoxyme |
| Pyridine, 5-bromo-2-[4-(dimethoxymethyl) |
| 1-(4-Bromo-2-methylphenyl)dihydro-2,4(1H |
| benzyl (2,5-dioxopyrrolidin-3-yl)carbama |
| benzyl 5-(benzyloxy)-2-bromobenzoate |
| 4-(3-Cyano-1H-indol-1-yl)-2-hydroxybenzo |
| 1-(5-(benzyloxy)-2-bromophenyl)ethan-1-o |
|
| Products |
| Catalogue Number |
Products |
CAS No. |
Assay |
| NX44651 | 3-trans-chloroallyloxyamine | 87851-77-2 | 95% |
| NX44652 | trans-4-Dimethylaminocrotonic acid hydrochloride | 848133-35-7 | 95% |
| NX44653 | trans-4-Dimethylaminocrotonic acid | 149586-32-3 | 95% |
| NX44654 | O-[(2E)-3-chloro-2-propen-1-yl]Hydroxylamine hydrochloride | 96992-71-1 | 95% |
| NX44655 | O-[(2E)-3-chloro-2-propen-1-yl]Hydroxylamine | 87851-77-2 | 95% |
| NX44656 | Cefatrizine | 51627-14-6 | 95% |
| NX44657 | Ceftazidime | 72558-82-8 | 95% |
| NX44658 | Cefixime | 79350-37-1 | 95% |
| NX44659 | (S)-3-AMINOBUTAN-1-OL | 61477-39-2 | 95% |
| NX44660 | (R)-3-Aminobutan-1-ol | 61477-40-5 | 95% |
| NX44661 | 1-Boc-piperidin-4-ylpropionic acid | 154775-43-6 | 95% |
| NX44662 | N-Boc-4-piperidin-4-yl-butyric acid | 142247-38-9 | 95% |
| NX44663 | Oxyresveratrol | 29700-22-9 | 95% |
| NX44664 | Piceatannol | 10083-24-6 | 95% |
| NX44665 | 4'-Methoxyresveratrol | 33626-08-3 | 95% |
| NX44666 | ACETYL-TRANS-RESVERATROL | 42206-94-0 | 95% |
| NX44667 | 3'-Hydroxypterostilbene | 475231-21-1 | 95% |
| NX44668 | (E)-3,5,4'-Trimethoxystilbene | 22255-22-7 | 95% |
| NX44669 | Rhapontigenin | 500-65-2 | 95% |
| NX44670 | Isorhapontigenin | 32507-66-7 | 95% |
| NX44671 | Pinostilbene | 42438-89-1 | 95% |
| NX44672 | (E)-4-[2-(3,4,5-trimethoxyphenyl)ethenyl]Phenol | 116519-00-7 | 95% |
| NX44673 | (E)-4'-hydroxy-3,5,3'-Trimethoxystilbene | 108957-72-8 | 95% |
| NX44674 | (Z)-Resveratrol | 61434-67-1 | 95% |
| NX44675 | (Z)-3,5,4'-Trimethoxystilbene | 94608-23-8 | 95% |
| NX44676 | (Z)-Pterostilbene | 441351-32-2 | 95% |
| NX44677 | 1-Ethylpyrazole | 2817-71-2 | 95% |
| NX44678 | 1-Ethyl-1,2,4-Triazole | 16778-70-4 | 95% |
| NX44679 | Decahydroquinoline | 2051-28-7 | 95% |
| NX44680 | Triethylbenzene-1,3,5-tricarboxylate | 4105-92-4 | 95% |
|
|
|
|
